heme101
跨領域 › 支持療護

血液疾病的疼痛處置

Pain Management in Hematology
跨領域 未策展 更新 2026-08-02

概覽

Buzzwords → Dx

Pain Type Drugs / Approach
Mild Acetaminophen + NSAID (caution renal, plt <50, GI)
Moderate Codeine, tramadol, low-dose oxycodone or hydromorphone
Severe / chronic cancer Long-acting morphine / oxycodone / hydromorphone / fentanyl patch + breakthrough short-acting q4h prn
VOC pain (SCD) IV opioid PCA: morphine or hydromorphone; goal pain control + IVF
Neuropathic pain Gabapentin, pregabalin, duloxetine, nortriptyline
Bone pain (MM, bone met) Bisphosphonates / denosumab + opioids + radiation; consider radium-223 (prostate met)
Breakthrough pain Short-acting opioid 10-20 % of total daily dose; titrate
Fentanyl patch Long-acting transdermal; 25 mcg/h ≈ ~50 mg morphine PO/d
Methadone Long-acting; NMDA + opioid; QT prolongation; complex conversion
Ketamine Adjunct for opioid-resistant pain
AVOID meperidine Norverbal accumulates → seizures, esp. renal failure or chronic use
Gabapentinoids + opioids Synergistic respiratory depression — caution
Opioid-induced constipation Universal ppx with stimulant laxative + osmotic
Opioid hyperalgesia Paradoxical ↑pain with high-dose; rotate opioid + ↓dose
Opioid use disorder (OUD) screening Cancer survivors, SCD; balance under-treatment vs OUD risk

分類與診斷

Workup

  • Pain assessment: location, character, intensity (VAS/NRS), temporal, radiation, alleviating/exacerbating, functional impact.
  • History: prior opioid use, OUD risk, allergies, comorbidities (renal, hepatic, GI, respiratory).
  • Labs: BMP, LFTs (drug metabolism + dose adjustment).

治療

Treatment Algorithm

flowchart TD
  A[Pain assessment] --> B{Severity + type}
  B -- mild --> C[Acetaminophen + NSAID<br>± adjuvants per type]
  B -- moderate --> D[+ Weak opioid (codeine, tramadol)<br>or low-dose oxycodone / hydromorphone]
  B -- severe / chronic cancer --> E[Long-acting opioid + breakthrough<br>+ adjuvants for neuropathic / bone]
  B -- SCD VOC --> F[IV opioid PCA<br>+ IVF + warmth + spirometry<br>NOT meperidine]
  B -- neuropathic --> G[Gabapentin / pregabalin / duloxetine / TCAs<br>± opioid]
  B -- bone pain --> H[Bisphosphonate / denosumab + RT + opioid<br>radium-223 for prostate met]
  C --> I[Constipation prophylaxis stimulant + osmotic]
  D --> I
  E --> I
  F --> I
  G --> I
  H --> I
  I --> J{Adequate control?}
  J -- no --> K[Rotate opioid<br>methadone consult<br>regional anesthesia / nerve block<br>palliative care]

陷阱與考點

Pearls / Pitfalls

  • Avoid meperidine in chronic pain or renal failure — norverbal metabolite accumulates → seizures, dysphoria.
  • Codeine is a prodrug (CYP2D6 → morphine); ultra-rapid metabolizers can have toxicity at standard doses; poor metabolizers ineffective. Avoid in children for tonsillectomy/adenoidectomy (FDA).
  • Tramadol has serotonergic + opioid effects → SS risk with SSRIs; seizure risk; lower opioid-equivalent.
  • Methadone has long, variable half-life + QT prolongation — use specialist guidance.
  • Fentanyl patch onset is slow (12–18 h) + lasts 72 h — NOT for acute pain control.
  • Buprenorphine + naloxone (Suboxone) for opioid use disorder — partial mu agonist; can complicate pain management; involve OUD specialist.
  • NSAIDs caution: avoid in plt <50, active bleeding, CKD, peptic ulcer disease, recent GI bleed.
  • Acetaminophen max 3 g/d (chronic) or 4 g/d (short-term); reduce in liver disease.
  • Opioid-induced constipation is universal — start stimulant laxative (senna) + osmotic (polyethylene glycol) prophylactically.
  • Opioid-induced respiratory depression treated with naloxone — short half-life (30–90 min) so re-dosing or infusion required for long-acting opioid overdose.
  • Adjuvants for neuropathic pain: gabapentin / pregabalin (titrate slowly, sedation), duloxetine (also depression), nortriptyline (anticholinergic).
  • Bone pain in MM: bisphosphonate (zoledronic acid / pamidronate) or denosumab + opioids + radiation; reduces fractures + pain.
  • Cancer pain: undertreatment is common — assess + titrate aggressively. Most cancer pain is opioid-responsive; switch routes (IV → SC → PO) as functional status changes.
  • Palliative care consultation for refractory pain, complex symptom management, psychosocial issues, end-of-life planning.
  • SCD chronic pain: balance VOC management + chronic pain management; opioid stewardship critical with hydroxyurea / disease-modifying therapies.

延伸

Cross-references

  • SCD VOC — opioid PCA
  • MM — bone pain + bisphosphonates
  • Cord compression — pain + dexamethasone
  • Opioid-induced nausea
  • Drug Regimens — opioids, adjuvants, chelators

相關題目

  • Q-211 — Avoid meperidine in chronic pain
  • Q-212 — Bone pain in MM — multimodal management
  • Q-213 — Methadone — opioid rotation

來源

Sources

Footnotes

  1. World Health Organization. WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents. 2018.

  2. Brandow AM, Carroll CP, Creary S, et al. American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Advances 2020;4(12):2656–2701. doi:10.1182/bloodadvances.2020001851.